What is the official website of Eurofins Central Laboratory ?

The official website of Eurofins Central Laboratory is https://eurofinscentrallaboratory.com/.

What is Eurofins Central Laboratory's cybersecurity risk score?

Eurofins Central Laboratory has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Eurofins Central Laboratory experienced?

According to Rankiteo, Eurofins Central Laboratory currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Eurofins Central Laboratory been affected by any supply chain cyber incidents ?

According to Rankiteo, Eurofins Central Laboratory has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Eurofins Central Laboratory have SOC 2 Type 1 certification ?

According to Rankiteo, Eurofins Central Laboratory is not certified under SOC 2 Type 1.

Does Eurofins Central Laboratory have SOC 2 Type 2 certification ?

According to Rankiteo, Eurofins Central Laboratory does not hold a SOC 2 Type 2 certification.

Does Eurofins Central Laboratory comply with GDPR ?

According to Rankiteo, Eurofins Central Laboratory is not listed as GDPR compliant.

Does Eurofins Central Laboratory have PCI DSS certification ?

According to Rankiteo, Eurofins Central Laboratory does not currently maintain PCI DSS compliance.

Does Eurofins Central Laboratory comply with HIPAA ?

According to Rankiteo, Eurofins Central Laboratory is not compliant with HIPAA regulations.

Does Eurofins Central Laboratory have ISO 27001 certification ?

According to Rankiteo,Eurofins Central Laboratory is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Eurofins Central Laboratory operate in ?

Eurofins Central Laboratory operates primarily in the Biotechnology Research industry.

How many employees does Eurofins Central Laboratory have ?

Eurofins Central Laboratory employs approximately 295 people worldwide.

Does Eurofins Central Laboratory own any subsidiaries ?

Eurofins Central Laboratory presently has no subsidiaries across any sectors.

How many LinkedIn followers does Eurofins Central Laboratory have ?

Eurofins Central Laboratory's official LinkedIn profile has approximately 12,333 followers.

What is the NAICS classification code for Eurofins Central Laboratory ?

Eurofins Central Laboratory is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Eurofins Central Laboratory have a Crunchbase profile ?

No, Eurofins Central Laboratory does not have a profile on Crunchbase.

Does Eurofins Central Laboratory have a LinkedIn profile ?

Yes, Eurofins Central Laboratory maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/eurofins-centrallaboratory.

How many cybersecurity incidents has Eurofins Central Laboratory experienced ?

As of October 16, 2026, Rankiteo reports that Eurofins Central Laboratory has not experienced any cybersecurity incidents.

How many peer or competitor companies does Eurofins Central Laboratory have ?

Eurofins Central Laboratory has an estimated 4,783 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

ECL

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Eurofins Central Laboratory Vendor Cyber Rating & Cyber Score

eurofinscentrallaboratory.com

Add Your Compliance Badge

Eurofins Central Laboratory is a global organization fully focused and dedicated to providing standardized, high quality global central laboratory services to support all phases of clinical trials. Eurofins Central Laboratory supports its customers with 4 wholly-owned and harmonized laboratory facilities located in the US, Europe, Singapore and China. With 25+ years of experience and scientific accomplishment, its laboratory testing portfolio has become one of the widest available in the biopharmaceutical industry and offers the synergy of integrated safety assessment, exploratory biomarkers, end point biomarkers, biomarker development, therapeutic drug monitoring, genomic testing and a full range of services to support vaccine

ECL

Eurofins Central Laboratory CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

ECL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for ECL

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Eurofins Central Laboratory in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Eurofins Central Laboratory in 2026.

Incident Types ECL vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Eurofins Central Laboratory in 2026.

Incident History - ECL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Eurofins Central Laboratory Subsidiaries

ECL

Biotechnology Research

Website: https://eurofinscentrallaboratory.com/

Company Size: 295

EurofinsBiotechnology Research

Eurofins Lancaster LaboratoriesBiotechnology Research

Eurofins PSS Insourcing SolutionsBiotechnology Research

Eurofins BioPharma Product Testing ItalyPharmaceutical Manufacturing

Eurofins IT Delivery CenterIT Services and IT Consulting

Eurofins AdvinusResearch Services

Eurofins Discovery Services IndiaResearch

Eurofins CDMO IndiaResearch Services

Eurofins Bioanalytical Services IndiaResearch Services

Eurofins Advinus Agrosciences IndiaResearch Services

Eurofins BioPharma Product Testing India Pharmaceutical Manufacturing

Eurofins Agroscience ServicesResearch

Eurofins Agroscience Biological SolutionsResearch

Eurofins Agroscience Seed ServicesResearch Services

Eurofins Agroscience Regulatory ConsultancyResearch Services

Eurofins Agroscience Biological AssessmentResearch Services

Eurofins Agroscience Environmental SafetyResearch

Eurofins Agroscience Consumer/Human SafetyResearch Services

Eurofins Agroscience Product ChemistryResearch Services

Eurofins do Brasil Análises de Alimentos e AmbientaisResearch Services

Eurofins Environment Testing (USA)Environmental Services

Eurofins GenomicsBiotechnology Research

Eurofins BiomnisMedical and Diagnostic Laboratories

Eurofins Food AssuranceProfessional Services

Eurofins Environment Testing FranceBiotechnology

Eurofins | Solutions DurablesServices de conseil en environnement

Eurofins Hygiène HospitalièreRecherche en biotechnologie

Eurofins Biopharma Product Testing (France)Pharmaceutical Manufacturing

Eurofins Analyses Alimentaires FranceBiotechnology Research

Eurofins DiscoveryBiotechnology

Eurofins ChileFood and Beverage Services

Eurofins Food, Feed & Water BeneluxBiotechnology Research

Eurofins Agro & HortiResearch Services

Eurofins DiscoverXBiotechnology Research

Eurofins Genomics AmericasBiotechnology

Eurofins CanadaBiotechnology Research

Eurofins Environment BeneluxEnvironmental Services

DiatherixBiotechnology Research

Eurofins Clinical DiagnosticsBiotechnology

Eurofins Danmark - LaboratoriumBiotechnology Research

Eurofins Product Testing Denmark A/SSecurity and Investigations

Eurofins Steins LaboratoriumBiotechnology Research

Eurofins ViracorMedical and Diagnostic Laboratories

ExPeCT™ anti-CD19 (FMC63) CAR TMedical and Diagnostic Laboratories

Eurofins Viracor CMV TestingBiotechnology Research

TTViWATCH™ - Torque Teno Virus qPCRMedical and Diagnostic Laboratories

Eurofins Clinical Trial SolutionsBiotechnology Research

Eurofins CDMOPharmaceutical Manufacturing

Eurofins CDMO AlphoraPharmaceutical Manufacturing

Eurofins US Food, Feed, & Supplement TestingBiotechnology Research

Loading…

Eurofins Central Laboratory Similar Companies

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Loading…

NEWS

Eurofins Central Laboratory CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

May 29, 2019 07:00 AM

Eurofins opens IoT security test lab

Eurofins Digital Testing has announced that its Cyber Security division has opened a new Security Test Lab to test and examine the security...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-110873

SUMMARY

Heym from 0.0.55 before 0.0.121 contains a privilege escalation vulnerability that allows shared collaborators to overwrite a workflow's error_workflow_id because the field is missing from OWNER_ONLY_EXECUTION_FIELDS. Attackers can point the error workflow to their own workflow with an HTTP node, and when the parent workflow errors the owner's decrypted credentials are injected and exfiltrated.

Published

Date2026-10-14

Updated

Date2026-10-14

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-110872

SUMMARY

Nodemailer from 3.0.0 before 10.0.10 contains a quadratic complexity denial of service vulnerability in the SMTP client reply parser in SMTPConnection._onData and isPartialResponse. A malicious SMTP server or on-path attacker can stream continuation lines without a completion line before authentication, blocking the Node.js event loop and exhausting memory.

Published

Date2026-10-14

Updated

Date2026-10-14

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.2

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.2

REFERENCES

CVE-2026-110871

SUMMARY

Nodemailer from 3.0.0 before 10.0.10 contains a denial of service vulnerability in MessageParser.parseHeaders that allows users to exhaust CPU through quadratic header unfolding. Attackers can supply large recipient lists or long headers that fold into tens of thousands of continuation lines, blocking the Node.js event loop during DKIM signing.

Published

Date2026-10-14

Updated

Date2026-10-14

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.8

REFERENCES

CVE-2026-110870

SUMMARY

Nodemailer from 3.0.0 before 10.0.13 contains an improper input validation vulnerability in its address parser that fails to strip RFC 5322 comments inside angle-bracket addresses. Attackers can supply recipients like a display name with a parenthesized comment in the domain, so illegal characters reach envelope.to and RCPT TO, causing rejected delivery or parser interpretation conflicts that bypass domain allow-lists.

Published

Date2026-10-14

Updated

Date2026-10-14

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-110869

SUMMARY

Nodemailer 3.0.0 before 10.0.13 has a regular expression denial of service in SMTPConnection._actionEHLO, whose four AUTH mechanism detection regexes contain overlapping whitespace sub-patterns that backtrack quadratically. A malicious or man-in-the-middle SMTP server can reply to EHLO with 250-AUTH, a long whitespace run and a non-matching token, blocking the Node.js event loop for tens of seconds to hours before authentication.

Published

Date2026-10-14

Updated

Date2026-10-14

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Eurofins Central Laboratory Vendor Cyber Rating & Cyber Score

ECL A.I CyberSecurity Scoring

Eurofins Central Laboratory CyberSecurity News & History

ECL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for ECL

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types ECL vs Biotechnology Research Industry Avg (This Year)

Incident History - ECL (X = Date, Y = Severity)

Eurofins Central Laboratory Subsidiaries

ECL

Eurofins Central Laboratory Similar Companies

Amgen

ICON plc

bioMérieux

Agilent Technologies

CSL

Charles River Laboratories

Roche

Avantor

The National Institutes of Health

Eurofins Central Laboratory CyberSecurity News

Eurofins opens IoT security test lab

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Eurofins Central Laboratory CyberSecurity News & History

ECL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for ECL

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types ECL vs Biotechnology Research Industry Avg (This Year)

Incident History - ECL (X = Date, Y = Severity)

Eurofins Central Laboratory Subsidiaries

ECL

Eurofins Central Laboratory Similar Companies

Amgen

ICON plc

bioMérieux

Agilent Technologies

CSL

Charles River Laboratories

Roche

Avantor

The National Institutes of Health

Eurofins Central Laboratory CyberSecurity News

Eurofins opens IoT security test lab

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo